Evercore ISI analyst Umer Raffat reinstates coverage on Biogen (NASDAQ: BIIB) with a Outperform rating.The analyst comments "That was a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE